Gefitinib vs Metformin

Gefitinib vs Metformin: Overview

This comparison examines the pharmacological differences between Gefitinib and Metformin.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Metformin — 4-9 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Metformin — C4H11N5.

Molecular Weight: Gefitinib — 446.9000 g/mol; Metformin — 129.1640 g/mol.

Type: Gefitinib — Small molecule; Metformin — Small molecule.